AirSculpt Technologies (AIRS) Fundamentals 2026 — Revenue Analysis | SniperIQ
AirSculpt Technologies (AIRS) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of
AirSculpt Technologies's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
AirSculpt Technologies runs a net profit margin of -7.4%, a gross margin of 60.6%, and an operating margin of -7.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
AirSculpt Technologies reported revenue of